🇺🇸 FDA
Pipeline program

Volixibat

VLX-401

Phase 2 small_molecule terminated

Quick answer

Volixibat for Intrahepatic Cholestasis of Pregnancy is a Phase 2 program (small_molecule) at Mirum Pharmaceuticals International B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Mirum Pharmaceuticals International B.V.
Indication
Intrahepatic Cholestasis of Pregnancy
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials